← Evidence map

ReviewPatient preference and adherence2013

Lanthanum carbonate for the control of hyperphosphatemia in chronic renal failure patients: a new oral powder formulation - safety, efficacy, and patient adherence.

M Jesús Lloret et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

6 papers cite it

2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 24235818